August 30, 2011 Two economists doubt accountable care organizations, a key tool for improving costs and quality under the federal health overhaul, will be able to temper the medical system's lust for the latest expensive technology. Costs and quality of care are are at stake.
August 30, 2011 Only people with lung cancer that tests positive for a particular genetic variation are candidates for treatment with Pfizer's twice-a-day cancer pill called Xalkori. Most of those who qualified in clinical tests saw dramatic shrinkage of their tumors.
August 24, 2011 Search giant Google has agreed to settle a federal probe into ads it ran for online Canadian pharmacies by forfeiting $500 million. The settlement assures the company will not face criminal charges.
Drug firms fear that being "liked" on Facebook could get them in trouble with the FDA.
August 22, 2011 Drug companies are taking down Facebook pages that refer to prescription drugs, fearing the ire of the FDA. But patients may lose out if they can't ask companies about how to use their products.
<iframe src="http://www.npr.org/player/embed/139859210/139859293" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Roche Genentech developed a new melanoma drug for people with advanced cases.
FABRICE COFFRINI/AFP/Getty Images
August 18, 2011 The drug was approved faster than many other drugs under review, and advocates of personalized medicine say this bodes well for other gene-based drugs in development.
There are more than 800 pairs of medications that look or sound alike, according to a patient safety group.
August 17, 2011 The government has a system in place to try to keep similar looking and sounding drugs from ending up on the market together. But the pharmaceutical industry has been pushing to kill that system.
Those who search for drug information online may be "drowned out in a sea of rogue results."
August 12, 2011 People searching online for information on prescription drugs have a 1 in 3 chance in being secretly hijacked to an online pharmacy instead, according to new research. Legitimate health information sites are being crowded out of search results by these search-redirection attacks.
A new drug called rivaroxaban may not require as many blood tests for patients with atrial fibrillation as the current drug on the market does.
August 10, 2011 Pharmaceutical companies have been working hard to make drugs to elbow out warfarin as the stroke-prevention drug for 2.3 million Americans with atrial fibrillation. A new study finds one of the contenders, rivaroxaban, is as effective as warfarin in preventing stroke, and doesn't require monitoring.
<iframe src="http://www.npr.org/player/embed/139402588/139519298" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
August 4, 2011 The Food and Drug Administration has approved the first antivenom against scorpion toxin. Called Anascorp, the treatment was developed in Mexico and will cost more than $10,000 per patient. For small children, who are at greatest risk from the bites, the treatment can be life-saving.
Antidepressants like these have become the second-most prescribed type of medicine in the U.S.
Joe Raedle/Getty Images
August 4, 2011 More and more people are taking antidepressant medications. Most antidepressants aren't prescribed by psychiatrists, raising questions about whether people are prescribed drugs they don't need or are suffering without help.
Johnson & Johnson is lowering the recommended top dose of Extra Strength Tylenol to reduce the risk of accidental overdose from acetaminophen.
July 28, 2011 Johnson & Johnson is lowering the maximum recommended dose for Extra Strenth Tylenol to six tablets a day from eight. Too much acetaminophen, the active ingredient in the painkiller, can cause liver damage.
July 27, 2011 A study finds the Medicare drug benefit is trimming around $12 billion in yearly spending on medical care. The savings are not enough to offset the total costs of the program.
July 21, 2011 Some research suggests there may be an increased risk of esophageal cancer for people who take some popular osteoporosis medicines. The Food and Drug Administration is reviewing the data but says there isn't enough information to draw a firm conclusion.
Bottles of antiretroviral drug Truvada, a medicine used in trials that showed a reduction in transmission of HIV between heterosexuals.
Justin Sullivan/Getty Images
July 14, 2011 Results from studies conducted in Africa confirm that drugs against HIV can reduce the risk of transmission of the virus between heterosexual partners. But where and with whom should the approach be used?
July 12, 2011 Last year was the worst ever for drug shortages at the nation's hospitals, according to a nationwide survey. Shortages have led to delays in patient care and made pharmacists scramble to find alternatives.
NPR thanks our sponsors
Become an NPR sponsor